1 Min Read
LONDON, Jan 11 (Reuters) * Ema assessed data related to safety concerns over tredaptive, pelzont and
trevaclyn * Ema -recommended that the marketing, supply and authorisations of these
medicines be suspended across the European union (EU).
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.